Skip to content

Clinical trials

Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 2 Country / region: Germany Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20043
20053
20061
20071
20081
20091
20111
20121
20132
20165
20172
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated3
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
German CLL Study Group10
Gilead Sciences3
AbbVie2
University of Ulm2
Biogen1
Celgene1
Cephalon1
Charite University, Berlin, Germany1
European Organisation for Research and Treatment of Cancer - EORTC1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell30
Leukemia4
Lymphoma, Follicular4
Lymphoma, Non-Hodgkin4
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Mantle-Cell3
Waldenstrom Macroglobulinemia3
Blast Crisis2
Burkitt Lymphoma2
Hodgkin Disease2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.